Literature DB >> 3652553

Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma.

V Grill1, F Mallardi, S Zorzet, L Perissin, T Giraldi.   

Abstract

Two lines of Lewis lung carcinoma with a different potential to metastasize spontaneously to the lungs have been examined for their cytological and histological characteristics. Metastatic potential appears to be related with parenchymal organization of the primary tumours, since large haemorrhagic areas containing detached tumour cells and the absence of endothelialized capillaries are observed only in the line with high metastatic potential. At the same time, the cytological characteristics of the cells of the two tumour lines are similar, and do not seem to be related with metastatic potential. After treatment with the selective antimetastatic drugs ICRF-159 and DM-COOK, and with DTIC, the histological appearance of the line with high metastatic potential becomes similar to that of the line with low metastatic potential. These data seem to indicate that the early phases of tumour spread occurring in the primary tumour are of relevance for metastatic potential and control by antimetastatic drugs, and suggest that for DTIC such antimetastatic action may participate to its clinical antitumour effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652553     DOI: 10.1007/BF00124305

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  12 in total

1.  Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.

Authors:  A J Salsbury; K Burrage; K Hellmann
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

2.  Inhibition of metastatic spread by I.C.R.F. 159: selective deletion of a malignant characteristic.

Authors:  A J Salsbury; K Burrage; K Hellmann
Journal:  Br Med J       Date:  1970-11-07

3.  Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.

Authors:  T Giraldi; G Sava; R Cherubino; G Bottiroli; G Mazzini
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

4.  Recent concepts of cancer metastasis and their implications for therapy.

Authors:  I J Fidler
Journal:  Cancer Treat Rep       Date:  1984-01

5.  Ultrastructure of the Lewis lung carcinoma.

Authors:  T Sato; K Takusagawa; N Asoo; F Ariji; K Shida; N Kumano; K Konno
Journal:  Eur J Cancer Clin Oncol       Date:  1982-04

6.  Cloning in vitro and in vivo of Lewis lung carcinoma: properties and characteristics.

Authors:  G Zupi; F Mauro; A Sacchi
Journal:  Br J Cancer Suppl       Date:  1980-04

7.  Lewis lung carcinoma lines with different metastatic behavior: response to ICRF-159.

Authors:  G Zupi; A Cavallari; C Greco; A Sacchi
Journal:  Anticancer Res       Date:  1984 Jan-Apr       Impact factor: 2.480

8.  Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.

Authors:  G Sava; T Giraldi; G Zupi; A Sacchi
Journal:  Invasion Metastasis       Date:  1984

9.  Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.

Authors:  T Giraldi; G Sava; R Cuman; C Nisi; L Lassiani
Journal:  Cancer Res       Date:  1981-06       Impact factor: 12.701

10.  In vitro and in vivo selection of two Lewis lung carcinoma cell lines.

Authors:  A Sacchi; A Corsi; M Caputo; G Zupi
Journal:  Tumori       Date:  1979-12-31
View more
  2 in total

1.  Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.

Authors:  G Sava; S Zorzet; L Perissin; S Pacor; L Lassiani; C Nisi; A Varnavas
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Antimetastatic action and toxicity on healthy tissues of Na[trans-RuCl4(DMSO)Im] in the mouse.

Authors:  R Gagliardi; G Sava; S Pacor; G Mestroni; E Alessio
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.